© Copyright - Neuro-Sys 2022
© Copyright - Neuro-Sys 2022
© Copyright - Neuro-Sys 2022
© Copyright - Neuro-Sys 2022
Your R&D
department
Neuro-Sys is a research-intensive and innovative organization specializing in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields.
Experts in
neurodegenerative
preclinical modelling
services
Latest
news
PUBLICATIONS August 30, 2022
Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence
Alexandre Henriques, Laura Rouvière, Elodie Giorla, Clémence Farrugia, Bilal El Waly, Philippe Poindron and Noelle Callizot
> More
PUBLICATIONS August 09, 2022
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System
Sighild Lemarchant, Mélissa Sourioux, Juliette Le Douce, Alexandre Henriques, Noelle Callizot, Sandrine Hugues, Mélissa Farinelli and Yann Godfrin
> More
POSTERS August 01, 2022
Poster presentation @AAIC 2022
"Neuroinflammation and microglial activation in Alzheimer’s Disease: in vitro and in vivo models of study."
Poster # N6P42
POSTERS July 13, 2022
Poster presentation @FENS 2022
"New in vivo model of Parkinson’s disease involving combined toxicity of alpha-synuclein oligomers and protofibrils, and chronic inhibition of GBA."
Poster # N6P41
POSTERS July 12, 2022
Poster presentation @FENS 2022
"Loss of GBA activity exacerbate the toxicity of alpha-synuclein oligomers and protofibrils in an in vitro model of Parkinson’s disease."
Poster # N6P40
EVENT February 03, 2022
Neuro-Sys will be exhibiting at AAIC in San Diego, 31 July-3 August 2022.
Booth #421
The Alzheimer’s Association International Conference is the largest and most influential international meeting dedicated to advancing dementia science
AWARDS August 29, 2021
Neuro-Sys inc. elected 2021 World's Best CRO of the year by Corporate Live Wire (UK).
We are very proud of this distinction, which congratulates several years of preclinical scientific excellence, the continuous efforts of our team of experts and the significant investments undertaken.
PUBLICATIONS August 30, 2021
NSP01, a green extract of Huperzia serrata with neuroprotective effects related to synergistic action of Huperzine A and polyphenols
Noelle Callizot, Maria-Letizia Campanari, Laura Rouvière, Guillaume Jacquemot, Alexandre Henriques, Elnur Garayev and Philippe Poindron
> More
PUBLICATIONS August 19, 2021
AZP2006, a new promising treatment for Alzheimer’s and related diseases
N Callizot, C Estrella, S Burlet, A Henriques, C Brantis, M Barrier, M L Campanari, P Verwaerde
> More
PLATFORMS March 8, 2021
The histology department is strengthened with the reinforcement of the team and the investment in the latest equipment.
> More
